Upadacitinib in Treatment of JAK/STAT Pathway Disorders With Activating Mutations

Clinical trial NCT07670156 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07670156
Sponsor: Lisa Satter
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

JAK1 GOF STAT1 GOF STAT3 GOF STAT5B GOF STAT6 GOF

Start date: 2026-08-01
Primary completion: 2028-08-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.